- Research Grants
Currently working as a MSL at pharmaceutical industry. Postdoctoral fellow at the Dept of Pharmacology at School of Medicine of Ribeirão Preto (FMRP-USP) and Dept of Neurobiology and Anatomy at University of Texas Science and Health Center at Houston (UT Health, Texas-USA) . She has a PhD in Neuroscience from Max-Planck Institute and Ludwig-Maximilian Universität (Munich, Germany), Master degree from University of São Paulo (FMRP-USP), and graduated in Pharmaceutical Science from University of São Paulo (FCFRP-USP). Has experience in Pharmacology, focusing on Neuropsicopharmacology, acting on the following subjects: serotonina, amígdala basolateral, imobilidade tônica, anxiety and vanilóides. (Source: Lattes Curriculum)
TRPV1 receptors (rTRPV1; transient receptor potential vanilloid type 1) are widely distributed in the central nervous system (CNS), as on prefrontal cortex and hippocampus, which suggests its involvement on the modulation of emotional responses. Its activation by exogenous or endogenous compounds promotes increase in cellular activity, mainly due to changes in glutamatergic synapses and...
AbstractTRPV1 receptors (rTRPV1, transient Receptor Potential Vanilloid Type 1) are widely expressed in several areas of the central nervous system (CNS), such as prefrontal cortex and hippocampus. This suggests their involvement during emotional responses modulation. rTRPV1 activation by exogenous or endogenous compounds increase cellular activity, mostly thru glutamatergic and nitric ...
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
|Data from Web of Science|